With 0.74 million shares changed hands, the volume of the stock remained heavier than its average volume of 57890.0 shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $3.2 whereas the lowest price it dropped to was $2.58. The 52-week range on CPIX shows that it touched its highest point at $7.25 and its lowest point at $1.85 during that stretch. It currently has a 1-year price target of $9.75. Beta for the stock currently stands at -0.47.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CPIX was up-trending over the past week, with a rise of 36.87%, but this was up by 42.11% over a month. Three-month performance dropped to -11.61% while six-month performance fell -45.80%. The stock gained 25.32% in the past year, while it has gained 22.73% so far this year.
Float and Shares Shorts:
At present, 14.96 million CPIX shares are outstanding with a float of 8.73 million shares on hand for trading. On 2025-11-28, short shares totaled 24522.0, which was 16.0 higher than short shares on 1761868800. In addition to Mr. A. J. Kazimi MBA as the firm’s Founder, Chairman, President & CEO, Mr. John Michael Hamm C.M.A. serves as its VP & CFO.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-09-30, CPIX reported revenue of $8292362.0 and operating income of -$1965260.0. The EBITDA in the recently reported quarter was -$510689.0 and diluted EPS was -$0.13.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. The surprise factor in the prior quarter was -$0.07.
